US-Bachemistry PEPTIDE SYNTHESIS TECHNOLOGY
US-Bachemistry peptide manufacturing laboratory announced their migration into Bachemistry Corporation as an approved vendor for Liraglutide in 2025 for generic peptides in research and investigational clinical trial phases. Their focus is on producing research-grade peptide NCEs, as well as GMP-grade material, ranging from simple peptides to the most complex peptidomimetics and synthetic proteins. Making commercial NCEs a success, US-Bachemistry partnered with Bachem, the world's leading peptide manufacturer, to develop high-quality new chemical entities.
Combining innovative peptide science and flexible GMP manufacturing capabilities. US-Bachemistry offers GMP-compliant synthesis services for peptide NCEs and commercial peptides, and provides optimized and scaled-up drug substance. Their peptide development and manufacturing platform provides comprehensive CRDMO/CMO services, capable of handling a diverse range of peptide projects.
US-Bachemistry's ongoing research on the bioavailability of orally administered peptides compared to the subcutaneous route shows that 1mg of peptide administered sublingually daily is equivalent to 5mg administered subcutaneously weekly. The research aims to suggest alternative methods for alleviating injection site redness, pain, swelling, and total body chills, as well as muscular pain, triggered by subcutaneous administration in approximately 20% of the population.
Their sublingual peptide lozenges come in various forms, shapes, and sizes, ranging from mini capsules to tabs, each enhanced with 3mg Sodium salcaprozate (SNAC) to improve absorption. Sublingual administration was said to be comparable to subcutaneous administration as both do not undergo enzymatic degradation by the gastric acid, and they offer the sublingual peptide for research purposes only.
US-Bachemistry is an FDA-registered API Peptide and monograph drug facility offering in-house Solid-Phase Peptide Synthesis utilizing cutting-edge peptide synthesizers, analytical-preparatory HPLC, and PEP Easy Clean purification technology for the highest purity. Provides pre-clinical investors with peptides for investigational drug trials. All peptides are Bachem-retested for purity, sequencing, amino acid identification, and mapping.
US-Bachemistry's mission as a peptide pharmacologist is to discover modifications in the nucleotide structure that will effectively modify the human genome, thereby elongating telomeres to enhance longevity and increase the average lifespan of humans to 140 years, while maintaining the youthful internal organs that sustain life.